Medicamentele pentru slăbit, asociate cu un risc mai mare de cădere a părului, arată un nou studiu

A recent study indicates that GLP-1 receptor agonists, used for weight loss, may increase the risk of hair loss. Researchers from the University of Pennsylvania analyzed data from nearly 50,000 patients, finding a 37% higher risk of alopecia compared to SGLT-2 inhibitors and a 68% higher risk compared to DPP-4 inhibitors. The study suggests that rapid weight loss and caloric restriction may contribute to this issue, rather than a direct effect of the medications. Regulatory authorities in the US and UK are investigating these findings, with numerous reports of hair loss associated with these drugs. Further research is needed to clarify the relationship between these medications and hair loss.